PLUS1
193.02
0.00 (0.0%)
0.00 (0.0%)
Upgrade to Real-Time
Premarket
Best deals to access real time data! |
|
USA Small Cap Basic
Monthly Subscription
for only
|
|
North American Extreme
Monthly Subscription
for only
|
|
USA Big Cap Pro
Monthly Subscription
for only
|
|
VAT not included
|
| Stock Name | Stock Symbol | Market | Stock Type |
|---|---|---|---|
| Allergan plc | AGN | NYSE | Common Stock |
| Price Change | Price Change % | Stock Price | Last Trade  |
|
|---|---|---|---|---|
| 0.00 | 0.0% | 193.02 | 18:00:00 |
| Open Price | Low Price | High Price | Close Price | Previous Close |
|---|---|---|---|---|
| 193.02 |
| Last Trade | Type | Quantity | Price | Currency |
|---|---|---|---|---|
| - | 0 | US$ 193.02 | USD |
Allergan Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| US$ 63.66B | 329.81M | 329.53M | US$ 16.09B | US$ -2.48B | -16.00 | -25.69 |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | US$ 2.96 | 1.53% | - | - |
Allergan News
| Date | Time | Source | News Article |
|---|---|---|---|
| 5/21/2020 | 15:31 | Edgar (US Regulatory) | Termination of Registration of a Class of Security Under.. |
| 5/19/2020 | 05:00 | Edgar (US Regulatory) | Notice of Effectiveness (effect) |
| 5/14/2020 | 15:59 | Edgar (US Regulatory) | Post-effective Amendment to Registration Statement (pos Am) |
| 5/14/2020 | 15:48 | Edgar (US Regulatory) | Post-effective Amendment to an Automatic Shelf Registration.. |
| 5/14/2020 | 15:44 | Edgar (US Regulatory) | Post-effective Amendment to Registration Statement (pos Am) |
| 5/14/2020 | 15:38 | Edgar (US Regulatory) | Post-effective Amendment to an S-8 Filing (s-8 Pos) |
| 5/14/2020 | 15:17 | Edgar (US Regulatory) | Current Report Filing (8-k) |
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical AGN Price Data
| Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 0.00 | 0.00 | 0.00 | 0.00 | 0 | 0.00 | 0.0% |
| 1 Month | 0.00 | 0.00 | 0.00 | 0.00 | 0 | 0.00 | 0.0% |
| 3 Months | 0.00 | 0.00 | 0.00 | 0.00 | 0 | 0.00 | 0.0% |
| 6 Months | 0.00 | 0.00 | 0.00 | 0.00 | 0 | 0.00 | 0.0% |
| 1 Year | 192.04 | 202.215 | 158.67 | 184.85 | 4,164,553 | 0.98 | 0.51% |
| 3 Years | 180.87 | 202.215 | 114.27 | 165.37 | 2,925,320 | 12.15 | 6.72% |
| 5 Years | 297.30 | 301.98 | 114.27 | 194.27 | 3,064,959 | -104.28 | -35.08% |
Allergan Description
| Allergan PLC is one of the largest specialty pharmaceutical manufacturers. It specializes in aesthetics, ophthalmology, women's health, gastrointestinal, and central nervous system products. The products offered by the company include Botox, Celexa, Fetzima, Refresh, Ozurdex and Zenpep among others. |
